Recent developments in heterocycle labeling with carbon isotopes - CEA - Commissariat à l’énergie atomique et aux énergies alternatives Access content directly
Journal Articles Journal of Labelled Compounds and Radiopharmaceuticals Year : 2018

Recent developments in heterocycle labeling with carbon isotopes


Heterocycles play an essential role in modern pharmaceutical and agrochemical developments, representing a very common structural unit in marketed drugs. Over the 46 new drugs approved in 2017 by the FDA, 25 contain in their structure an heterocyclic core. The development of novel and straightforward labeling strategies for the effective insertion of carbon isotopes into heterocylic scaffolds is an inspiring and vibrant field of research. The use of carbon-11, carbon-13 and carbon-14 isotopes is well established in life science and particularly in pharmaceutical and agrochemical industry. Their introduction into small organic molecules represents a crucial step for the radiochemists. Since the labeling should occur in metabolically stable positions and in the shortest synthetic route, their incorporation into the heterocycles represent a viable solution. This review summarizes recent contributions to this area of research through the analysis of different industrial and academic cases.
Fichier principal
Vignette du fichier
JLCR Review, Audisio.pdf (1.86 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

cea-02420525 , version 1 (20-12-2019)



Antonio del Vecchio, Gianluca Destro, Frédéric Taran, Davide Audisio. Recent developments in heterocycle labeling with carbon isotopes. Journal of Labelled Compounds and Radiopharmaceuticals, 2018, 61 (13), pp.988-1007. ⟨10.1002/jlcr.3666⟩. ⟨cea-02420525⟩
125 View
798 Download



Gmail Facebook X LinkedIn More